Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer.

Liu, Jin; Wang, Chuifang; Liu, Xiangyan; Wang, Yu; Liu, Haibo; Ren, Guohua; Zhu, Liangming; Sun, Zhigang; Chen, Zhitao

Liu, Jin; Wang, Chuifang; Liu, Xiangyan; Wang, Yu; Liu, Haibo; Ren, Guohua; Zhu, Liangming; Sun, Zhigang; Chen, Zhitao.

Afiliação

Liu J; Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Wang C; Department of Thoracic Surgery, Liaocheng Tumor Hospital, Liaocheng, Shandong 252000, P.R. China.
Liu X; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Wang Y; Department of Gastroenterology, Zhangqiu People's Hospital, Zhangqiu, Shandong 250200, P.R. China.
Liu H; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
Ren G; Department of Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China.
Zhu L; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
Sun Z; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
Chen Z; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.